Virtus ETF Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,448
Closed -$330K 467
2024
Q4
$330K Buy
9,448
+1,439
+18% +$50.3K 0.13% 228
2024
Q3
$321K Hold
8,009
0.15% 226
2024
Q2
$382K Buy
8,009
+361
+5% +$17.2K 0.19% 185
2024
Q1
$332K Buy
7,648
+1,100
+17% +$47.7K 0.18% 220
2023
Q4
$331K Sell
6,548
-909
-12% -$46K 0.21% 205
2023
Q3
$338K Sell
7,457
-961
-11% -$43.6K 0.21% 194
2023
Q2
$345K Buy
8,418
+374
+5% +$15.3K 0.2% 156
2023
Q1
$287K Buy
8,044
+144
+2% +$5.15K 0.16% 242
2022
Q4
$298K Buy
7,900
+871
+12% +$32.9K 0.16% 268
2022
Q3
$311K Buy
7,029
+104
+2% +$4.6K 0.12% 271
2022
Q2
$256K Sell
6,925
-5,371
-44% -$199K 0.09% 292
2022
Q1
$455K Hold
12,296
0.2% 136
2021
Q4
$374K Buy
12,296
+194
+2% +$5.9K 0.14% 173
2021
Q3
$406K Sell
12,102
-1,110
-8% -$37.2K 0.18% 170
2021
Q2
$527K Buy
13,212
+128
+1% +$5.11K 0.22% 131
2021
Q1
$588K Buy
13,084
+359
+3% +$16.1K 0.25% 129
2020
Q4
$719K Buy
12,725
+2,712
+27% +$153K 0.3% 94
2020
Q3
$475K Buy
10,013
+843
+9% +$40K 0.25% 143
2020
Q2
$541K Sell
9,170
-159
-2% -$9.38K 0.26% 140
2020
Q1
$441K Sell
9,329
-787
-8% -$37.2K 0.18% 183
2019
Q4
$611K Sell
10,116
-1,040
-9% -$62.8K 0.1% 186
2019
Q3
$668K Sell
11,156
-1,881
-14% -$113K 0.13% 167
2019
Q2
$838K Buy
+13,037
New +$838K 0.18% 175
2019
Q1
Sell
-11,369
Closed -$615K 198
2018
Q4
$615K Sell
11,369
-5,163
-31% -$279K 0.11% 40
2018
Q3
$853K Buy
16,532
+1,114
+7% +$57.5K 0.09% 59
2018
Q2
$642K Sell
15,418
-2,164
-12% -$90.1K 0.57% 125
2018
Q1
$775K Sell
17,582
-1,028
-6% -$45.3K 0.67% 77
2017
Q4
$936K Sell
18,610
-1,765
-9% -$88.8K 1.17% 38
2017
Q3
$1.03M Hold
20,375
0.14% 57
2017
Q2
$1.04M Sell
20,375
-1,506
-7% -$76.6K 0.15% 60
2017
Q1
$880K Buy
21,881
+2,104
+11% +$84.6K 0.16% 75
2016
Q4
$946K Sell
19,777
-8,079
-29% -$386K 0.28% 59
2016
Q3
$1.02M Buy
27,856
+3,511
+14% +$129K 0.49% 34
2016
Q2
$567K Buy
24,345
+13,898
+133% +$324K 0.42% 31
2016
Q1
$423K Hold
10,447
0.58% 47
2015
Q4
$647K Buy
+10,447
New +$647K 1.78% 10